Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $2,530,033 were purchased by Dudum Andrew on Jul 16 ’25. At $50.27 per share, Dudum Andrew acquired 50,326 shares.
Also, Boughton Soleil sold 2,572 shares, netting a total of over 122,993 in proceeds. Following the sale of shares at $47.82 each, the insider now holds 158,165 shares.
Before that, Okupe Oluyemi had sold 11,581 shares from its account. In a trade valued at $552,418, the Chief Financial Officer traded Hims & Hers Health Inc shares for $47.70 each. Upon closing the transaction, the insider’s holdings decreased to 11,581 shares, worth approximately $2.7 million.
As published in a research note from Needham on June 23, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early June. As of April 29, 2025, TD Cowen has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on February 18, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for HIMS stock which previously was a “an Overweight”.
Analyzing HIMS Stock Performance
On last trading session,, Hims & Hers Health Inc [NYSE: HIMS] plunged -3.59% to $49.99. The stock’s lowest price that day was $49.68, but it reached a high of $52.08 in the same session. During the last five days, there has been a drop of approximately -0.56%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 118.87%.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
RSI (Relative Strength Index) is 48.95 on the 14-day chart, showing neutral technical sentiment.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.65 million shares to 61.69 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 62.34 million shares. A decline of -1.05% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.47 of the overall float, the days-to-cover ratio (short ratio) decline to 1.47.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 6.08% from the previous closing price of $51.85. Analysts anticipate Hims & Hers Health Inc stock to reach 68 by 2025, with the lowest price target being 30. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 10, 2025, Citigroup assigned a price target of “a Sell” to the stock and downgraded coverage with a $25.
